MARKET

SPNE

SPNE

SeaSpine Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.66
+1.38
+6.80%
Pre Market: 21.66 0 0.00% 08:18 05/06 EDT
OPEN
20.74
PREV CLOSE
20.28
HIGH
21.75
LOW
19.97
VOLUME
1
TURNOVER
--
52 WEEK HIGH
22.97
52 WEEK LOW
8.78
MARKET CAP
718.27M
P/E (TTM)
-13.7848
1D
5D
1M
3M
1Y
5Y
DLA Piper advises SeaSpine Holdings Corporation in its US$101 million public offering
DLA Piper represented SeaSpine Holdings Corporation (NASDAQ: SPNE) in its recent public offering of 5,175,000 shares of its common stock at a price of $19.50 per share, including the exercise of the underwriters' option to purchase 675,000 shares of common...
PR Newswire · 20h ago
Canaccord Genuity Maintains Buy on SeaSpine Holdings, Raises Price Target to $30
Canaccord Genuity maintains SeaSpine Holdings (NASDAQ:SPNE) with a Buy and raises the price target from $28 to $30.
Benzinga · 1d ago
SeaSpine Holdings (SPNE) Gets a Buy Rating from Canaccord Genuity
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on SeaSpine Holdings (SPNE), with a price target of $30.00. The
SmarterAnalyst · 1d ago
--Canaccord Genuity Adjusts SeaSpine Holdings PT to $30 From $28, Maintains Buy Rating
MT Newswires · 1d ago
8-K: SeaSpine Holdings Corp
(EDGAR Online via COMTEX) -- false000163776100016377612021-05-032021-05-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 2d ago
BTIG Remains a Buy on SeaSpine Holdings (SPNE)
BTIG analyst Ryan Zimmerman maintained a Buy rating on SeaSpine Holdings (SPNE) yesterday and set a price target of $28.00. The company's shares closed
SmarterAnalyst · 2d ago
10-Q: SEASPINE HOLDINGS CORP
Edgar Online - (EDG = 10Q, 10K) · 2d ago
SeaSpine Holdings 1Q Rev $42M >SPNE
SeaSpine Holdings 1Q Rev $42M >SPNE
Dow Jones · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SPNE. Analyze the recent business situations of SeaSpine Hldg through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SPNE stock price target is 28.03 with a high estimate of 32.25 and a low estimate of 24.00.
EPS
Institutional Holdings
Institutions: 144
Institutional Holdings: 21.63M
% Owned: 67.10%
Shares Outstanding: 33.16M
TypeInstitutionsShares
Increased
42
989.30K
New
9
540.54K
Decreased
24
660.34K
Sold Out
8
951.00K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.94%
Healthcare Equipment & Supplies
-0.58%
Key Executives
Non-Executive Chairman/Independent Director
Kirtley Stephenson
President/Chief Executive Officer/Director
Keith Valentine
Chief Financial Officer/Senior Vice President/Treasurer
John Bostjancic
Senior Vice President
Dennis Cirino
Senior Vice President
Tyler Lipschultz
Vice President/General Counsel/Secretary
Patrick Keran
Vice President/Director of Sales
John Winge
Lead Director/Independent Director
Stuart Essig
Director
Shweta Maniar
Independent Director
Keith Bradley
Independent Director
Michael Fekete
Independent Director
Renee Gaeta
Independent Director
Kim Commins-Tzoumakas
Independent Director
John Henneman
No Data
About SPNE
SeaSpine Holdings Corporation is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company offers a portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. Its spinal implants portfolio consists of a line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Orthobiologics products are used in orthopedic and dental procedures and consist of a range of bone graft substitutes to address the key elements of bone regeneration -osteoinduction, osteoconduction and osteogenesis. Spinal implant portfolio consists of a line of products for spinal decompression alignment and stabilization.

Webull offers kinds of SeaSpine Holdings Corp stock information, including NASDAQ:SPNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPNE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SPNE stock methods without spending real money on the virtual paper trading platform.